Table 1.
Correlation between netrin-1 and BVES expression and clinicopathological characteristics of 37 HCCs
| Variable | Samples (n = 37) | netrin-1 | BVES | ||
|---|---|---|---|---|---|
|
| |||||
| high expression | P-value | low expression | P-value | ||
| Gender | |||||
| Male | 28 | 22 | 0.091 | 20 | 0.229 |
| Female | 9 | 4 | 4 | ||
| Age | |||||
| ≥ 60 | 8 | 5 | 0.672 | 4 | 0.413 |
| < 60 | 29 | 21 | 20 | ||
| Tumour number | |||||
| Multiple | 11 | 7 | 0.699 | 5 | 0.143 |
| Solitary | 26 | 19 | 19 | ||
| Tumour size (cm) | |||||
| ≥ 5 | 20 | 16 | 0.279 | 14 | 0.512 |
| < 5 | 17 | 10 | 10 | ||
| Tumour differentiation | |||||
| Moderately and poorly | 22 | 17 | 0.295 | 16 | 0.300 |
| Well | 15 | 9 | 8 | ||
| Portal invasion | |||||
| Present | 12 | 8 | 1.000 | 9 | 0.476 |
| Absent | 25 | 18 | 15 | ||
| Lymph node metastases | |||||
| Present | 10 | 7 | 1.000 | 7 | 1.000 |
| Absent | 27 | 19 | 17 | ||
| HBsAg | |||||
| Present | 30 | 22 | 0.403 | 19 | 1.000 |
| Absent | 7 | 4 | 5 | ||
Abbreviation: HBsAg, hepatitis B surface antige.